Literature DB >> 31701157

Esophageal Position Affects Short-Term Outcomes After Minimally Invasive Esophagectomy: A Retrospective Multicenter Study.

Tomoyuki Uchihara1, Naoya Yoshida1, Yoshifumi Baba1, Yuichiro Nakashima2, Yasue Kimura3, Hiroshi Saeki2, Shinsuke Takeno4, Noriaki Sadanaga5, Masahiko Ikebe6, Masaru Morita6, Yasushi Toh6, Atsushi Nanashima4, Yoshihiko Maehara2, Hideo Baba7.   

Abstract

BACKGROUND: Anatomical esophageal position may affect the short-term outcomes after minimally invasive esophagectomy (MIE). A previous single-institutional retrospective study suggested that the presence of a left-sided esophagus (LSE) made MIE more difficult and increased the incidence of postoperative complications.
METHODS: The current study was a multicenter retrospective study of 303 patients with esophageal cancer who underwent MIE at six esophageal cancer high-volume centers in Kyushu, Japan, between April 2011 and August 2016. The patients were divided into the LSE (66 patients) and non-LSE groups (237 patients) based on the esophageal position on computed tomography images obtained with the patients in the supine position.
RESULTS: Univariate analysis showed that patients with LSE were significantly older than those with non-LSE (69 ± 8 vs. 65 ± 9 years; P = 0.002), had a significantly greater incidence of cardiovascular comorbidity (65.2% vs. 47.7%; P = 0.013), and a significantly longer operating time (612 ± 112 vs. 579 ± 102 min; P = 0.025). Logistic regression analysis verified that LSE was an independent risk factor for the incidence of pneumonia (odds ratio 3.3, 95% confidence interval 1.254-8.695; P = 0.016).
CONCLUSIONS: The presence of a LSE can increase the procedural difficulty of MIE and the incidence of morbidity after MIE. Thus, careful attention must be paid to anatomical esophageal position before performing MIE.

Entities:  

Mesh:

Year:  2020        PMID: 31701157     DOI: 10.1007/s00268-019-05273-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  30 in total

1.  Incidence and risk factors for respiratory complications in patients undergoing esophagectomy for malignancy: a NSQIP analysis.

Authors:  Daniela Molena; Benedetto Mungo; Miloslawa Stem; Anne O Lidor
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-12-13

2.  Randomized Controlled Study to Evaluate the Efficacy of a Preoperative Respiratory Rehabilitation Program to Prevent Postoperative Pulmonary Complications after Esophagectomy.

Authors:  Ippei Yamana; Shinsuke Takeno; Tatsuya Hashimoto; Kenji Maki; Ryosuke Shibata; Hironari Shiwaku; Hideki Shimaoka; Etsuji Shiota; Yuichi Yamashita
Journal:  Dig Surg       Date:  2015-07-14       Impact factor: 2.588

3.  Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model.

Authors:  Daniel P Raymond; Christopher W Seder; Cameron D Wright; Mitchell J Magee; Andrzej S Kosinski; Stephen D Cassivi; Eric L Grogan; Shanda H Blackmon; Mark S Allen; Bernard J Park; William R Burfeind; Andrew C Chang; Malcolm M DeCamp; David W Wormuth; Felix G Fernandez; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2016-05-28       Impact factor: 4.330

4.  Risk factors for pulmonary morbidities after minimally invasive esophagectomy for esophageal cancer.

Authors:  Tomoyuki Uchihara; Naoya Yoshida; Yoshifumi Baba; Taisuke Yagi; Tasuku Toihata; Eri Oda; Daisuke Kuroda; Tsugio Eto; Mayuko Ohuchi; Kenichi Nakamura; Hiroshi Sawayama; Koichi Kinoshita; Masaaki Iwatsuki; Takatsugu Ishimoto; Yasuo Sakamoto; Hideo Baba
Journal:  Surg Endosc       Date:  2017-12-22       Impact factor: 4.584

5.  Effect of Esophagus Position on Surgical Difficulty and Postoperative Morbidities After Thoracoscopic Esophagectomy.

Authors:  Naoya Yoshida; Yoshifumi Baba; Hironobu Shigaki; Shinya Shiraishi; Kazuto Harada; Masayuki Watanabe; Masaaki Iwatsuki; Junji Kurashige; Yasuo Sakamoto; Yuji Miyamoto; Takatsugu Ishimoto; Keisuke Kosumi; Ryuma Tokunaga; Yasuyuki Yamashita; Hideo Baba
Journal:  Semin Thorac Cardiovasc Surg       Date:  2015-12-18

6.  Preoperative Smoking Cessation is Integral to the Prevention of Postoperative Morbidities in Minimally Invasive Esophagectomy.

Authors:  Naoya Yoshida; Kenichi Nakamura; Daisuke Kuroda; Yoshifumi Baba; Yuji Miyamoto; Masaaki Iwatsuki; Yukiharu Hiyoshi; Takatsugu Ishimoto; Yu Imamura; Masayuki Watanabe; Hideo Baba
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

7.  Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005-2008.

Authors:  Birat Dhungel; Brian S Diggs; John G Hunter; Brett C Sheppard; John T Vetto; James P Dolan
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

8.  Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients.

Authors:  Yasunori Akutsu; Hisahiro Matsubara; Kiyohiko Shuto; Toru Shiratori; Masaya Uesato; Yukimasa Miyazawa; Isamu Hoshino; Kentaro Murakami; Akihiro Usui; Masayuki Kano; Hideaki Miyauchi
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

9.  Duration of Smoking Cessation and Postoperative Morbidity After Esophagectomy for Esophageal Cancer: How Long Should Patients Stop Smoking Before Surgery?

Authors:  Naoya Yoshida; Yoshifumi Baba; Yukiharu Hiyoshi; Hironobu Shigaki; Junji Kurashige; Yasuo Sakamoto; Yuji Miyamoto; Masaaki Iwatsuki; Takatsugu Ishimoto; Keisuke Kosumi; Hidetaka Sugihara; Kazuto Harada; Ryuma Tokunaga; Daisuke Izumi; Masayuki Watanabe; Hideo Baba
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

10.  Quality of life after robot-assisted transmediastinal radical surgery for esophageal cancer.

Authors:  Shuntaro Yoshimura; Kazuhiko Mori; Yukinori Yamagata; Susumu Aikou; Koichi Yagi; Masato Nishida; Hiroharu Yamashita; Sachiyo Nomura; Yasuyuki Seto
Journal:  Surg Endosc       Date:  2018-03-01       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.